175 related articles for article (PubMed ID: 38409124)
1. Engineering self-deliverable ribonucleoproteins for genome editing in the brain.
Chen K; Stahl EC; Kang MH; Xu B; Allen R; Trinidad M; Doudna JA
Nat Commun; 2024 Feb; 15(1):1727. PubMed ID: 38409124
[TBL] [Abstract][Full Text] [Related]
2. Engineering self-deliverable ribonucleoproteins for genome editing in the brain.
Chen K; Stahl EC; Kang MH; Xu B; Allen R; Trinidad M; Doudna JA
bioRxiv; 2023 Nov; ():. PubMed ID: 38014180
[TBL] [Abstract][Full Text] [Related]
3. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs.
Stahl EC; Sabo JK; Kang MH; Allen R; Applegate E; Kim SE; Kwon Y; Seth A; Lemus N; Salinas-Rios V; Soczek KM; Trinidad M; Vo LT; Jeans C; Wozniak A; Morris T; Kimberlin A; Foti T; Savage DF; Doudna JA
Mol Ther; 2023 Aug; 31(8):2422-2438. PubMed ID: 37403358
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
5. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins.
Metzger JM; Wang Y; Neuman SS; Snow KJ; Murray SA; Lutz CM; Bondarenko V; Felton J; Gimse K; Xie R; Li D; Zhao Y; Flowers MT; Simmons HA; Roy S; Saha K; Levine JE; Emborg ME; Gong S
Biomaterials; 2023 Feb; 293():121959. PubMed ID: 36527789
[TBL] [Abstract][Full Text] [Related]
6. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.
Wei T; Cheng Q; Min YL; Olson EN; Siegwart DJ
Nat Commun; 2020 Jun; 11(1):3232. PubMed ID: 32591530
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of Cas9 and single-guided RNAs in
Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
Commun Biol; 2019; 2():161. PubMed ID: 31069270
[TBL] [Abstract][Full Text] [Related]
8. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing.
Liang S; Ma N; Li X; Yun K; Meng QF; Ma K; Yue L; Rao L; Chen X; Wang Z
Nano Lett; 2024 Jun; 24(23):6872-6880. PubMed ID: 38683656
[TBL] [Abstract][Full Text] [Related]
9. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.
Martin RM; Ikeda K; Cromer MK; Uchida N; Nishimura T; Romano R; Tong AJ; Lemgart VT; Camarena J; Pavel-Dinu M; Sindhu C; Wiebking V; Vaidyanathan S; Dever DP; Bak RO; Laustsen A; Lesch BJ; Jakobsen MR; Sebastiano V; Nakauchi H; Porteus MH
Cell Stem Cell; 2019 May; 24(5):821-828.e5. PubMed ID: 31051134
[TBL] [Abstract][Full Text] [Related]
10. Pursuit of chlorovirus genetic transformation and CRISPR/Cas9-mediated gene editing.
Noel EA; Weeks DP; Van Etten JL
PLoS One; 2021; 16(10):e0252696. PubMed ID: 34673785
[TBL] [Abstract][Full Text] [Related]
11. A pipeline for precise and efficient genome editing by sgRNA-Cas9 RNPs in
Nyberg KG; Nguyen JQ; Kwon YJ; Blythe S; Beitel GJ; Carthew R
Fly (Austin); 2020; 14(1-4):34-48. PubMed ID: 33016195
[TBL] [Abstract][Full Text] [Related]
12. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
[TBL] [Abstract][Full Text] [Related]
13. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
[TBL] [Abstract][Full Text] [Related]
14. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
[TBL] [Abstract][Full Text] [Related]
16. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
Fang H; Culver JN; Niedz RP; Qi Y
Methods Mol Biol; 2023; 2653():153-171. PubMed ID: 36995625
[TBL] [Abstract][Full Text] [Related]
17. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
18. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
Elife; 2021 Dec; 10():. PubMed ID: 34898428
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
20. Confinement in Dual-Chain-Locked DNA Origami Nanocages Programs Marker-Responsive Delivery of CRISPR/Cas9 Ribonucleoproteins.
Xu Z; Dong Y; Ma N; Zhu X; Zhang X; Yin H; Chen S; Zhu JJ; Tian Y; Min Q
J Am Chem Soc; 2023 Dec; 145(49):26557-26568. PubMed ID: 38039555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
